logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. DEPRES II (Depression Research in European Society II) : A patient survey of the symptoms, disability and current management of depression in the community.

    Article - En anglais

    The first pan-European survey of depression in the community (DEPRES I) demonstrated that 17% of the general population suffer from depression (major depression, minor depression, or depressive symptoms).

    This article describes findings from a second phase of DEPRES (DEPRES II), in which detailed interviews based on a semi-structured questionnaire (78 questions) were conducted with 1884 DEPRES I participants who had suffered from depression and who consulted a healthcare professional about their symptoms during the previous 6 months.

    The mean time from onset of depression was 45 months, and the most commonly experienced symptoms during the latest period were low mood (76%), tiredness (73%) and sleep problems (63%). During the previous 6 months, respondents had been unable to undertake normal activities because of their depression for a mean of 30 days, and a mean of 20 days of work had been lost to depression by those in paid employment.

    Approximately one-third of respondents (30%) had received an antidepressant during the latest period of depression.

    Significantly more respondents given a selective serotonin reputake inhibitor found that their treatment made them feel more like their normal self than those given a tricyclic antidepressant, and fewer reported treatment-related concentration lapses, weight problems, and heavy-headedness (all P<0.05). (...)

    Mots-clés Pascal : Antidépresseur, Psychotrope, Utilisation, Etat dépressif, Trouble humeur, Symptomatologie, Evolution, Homme, Epidémiologie, Europe, Chimiothérapie, Prescription médicale, Efficacité traitement

    Mots-clés Pascal anglais : Antidepressant agent, Psychotropic, Use, Depression, Mood disorder, Symptomatology, Evolution, Human, Epidemiology, Europe, Chemotherapy, Medical prescription, Treatment efficiency

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 99-0296631

    Code Inist : 002B18C07A. Création : 16/11/1999.